China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A randomized controlled trial comparing the efficacy and safety of Hybutimibe Tablets plus atorvastatin versus atorvastatin in the treatment of chronic kidney disease with hypercholesterolemia'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131738
Registration Time: 2026/09/06
Type: Interventional study
Primary Sponsor: Shantou Central Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=299515
Published by HT Digital Content Services with permission from Health Daily Digest....